サマリー

加齢黄斑変性の世界市場 2024-2028
加齢黄斑変性市場は2023-2028年に51億米ドル成長し、予測期間中のCAGRは6.54%で加速すると予測されます。当レポートでは、加齢黄斑変性市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。AMDの高い有病率、AMD治療薬の強力なパイプラインと承認見込み、老年人口の増加が市場を牽引しています。
Technavio社の加齢黄斑変性市場は以下のように分類されます：
タイプ別
- 湿性AMD
- ドライ型AMD
流通チャネル別
- 病院薬局
- 専門薬局
- オンライン薬局
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、AMD治療のためのベンダーによる戦略的提携が、今後数年間の加齢黄斑変性市場の成長を促進する主要な理由の1つであると特定している。また、AMD予防のための遺伝子治療の開発やAMDに対する意識の高まりは、市場の大きな需要につながるでしょう。
本レポートでは、加齢黄斑変性市場について以下の領域をカバーしています：
- 加齢黄斑変性市場規模
- 加齢黄斑変性市場予測
- 加齢黄斑変性市場産業分析
強固なベンダー分析は、クライアントが市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie Inc.、Adverum Biotechnologies Inc.、Alimera Sciences Inc.、Alkeus Pharmaceuticals Inc.、Amgen Inc.、Apellis Pharmaceuticals Inc.、Bausch Health Companies Inc.、Bayer AG、Bio Thera Bio Pharmaceutical Co.Ltd.、Biocon Ltd.、F. Hoffmann La Roche Ltd.、IVERIC bio Inc.、Lupin Ltd.、Novartis AG、Outlook Therapeutics Inc.、Pfizer Inc.、Regeneron Pharmaceuticals Inc.、Ribomic Inc.、Viatris Inc.、Xbrane Biopharma AB。また、加齢黄斑変性市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/age-related-macular-degeneration-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global age-related macular degeneration (AMD) market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global age-related macular degeneration (amd) market 2018 - 2022 ($ billion)
o 4.2 Type Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
o 4.3 Distribution Channel Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Wet AMD - Market size and forecast 2023-2028
o Exhibit 34: Chart on Wet AMD - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Wet AMD - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Wet AMD - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Wet AMD - Year-over-year growth 2023-2028 (%)
o 6.4 Dry AMD - Market size and forecast 2023-2028
o Exhibit 38: Chart on Dry AMD - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Dry AMD - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Dry AMD - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Dry AMD - Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ billion)
o Exhibit 43: Data Table on Market opportunity by Type ($ billion)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel - Market share 2023-2028 (%)
o Exhibit 45: Data Table on Distribution Channel - Market share 2023-2028 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Hospital pharmacy - Market size and forecast 2023-2028
o Exhibit 48: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 49: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 50: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
o 7.4 Specialty pharmacy - Market size and forecast 2023-2028
o Exhibit 52: Chart on Specialty pharmacy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on Specialty pharmacy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on Specialty pharmacy - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Specialty pharmacy - Year-over-year growth 2023-2028 (%)
o 7.5 Online pharmacy - Market size and forecast 2023-2028
o Exhibit 56: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 57: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 60: Market opportunity by Distribution Channel ($ billion)
o Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 UK - Market size and forecast 2023-2028
o Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.10 France - Market size and forecast 2023-2028
o Exhibit 95: Chart on France - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on France - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on France - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on France - Year-over-year growth 2023-2028 (%)
o 9.11 Japan - Market size and forecast 2023-2028
o Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 111: AbbVie Inc. - Overview
o Exhibit 112: AbbVie Inc. - Product / Service
o Exhibit 113: AbbVie Inc. - Key news
o Exhibit 114: AbbVie Inc. - Key offerings
o 12.4 Alkeus Pharmaceuticals Inc.
o Exhibit 115: Alkeus Pharmaceuticals Inc. - Overview
o Exhibit 116: Alkeus Pharmaceuticals Inc. - Product / Service
o Exhibit 117: Alkeus Pharmaceuticals Inc. - Key offerings
o 12.5 Amgen Inc.
o Exhibit 118: Amgen Inc. - Overview
o Exhibit 119: Amgen Inc. - Product / Service
o Exhibit 120: Amgen Inc. - Key offerings
o 12.6 Apellis Pharmaceuticals Inc.
o Exhibit 121: Apellis Pharmaceuticals Inc. - Overview
o Exhibit 122: Apellis Pharmaceuticals Inc. - Product / Service
o Exhibit 123: Apellis Pharmaceuticals Inc. - Key offerings
o 12.7 Bausch Health Companies Inc.
o Exhibit 124: Bausch Health Companies Inc. - Overview
o Exhibit 125: Bausch Health Companies Inc. - Business segments
o Exhibit 126: Bausch Health Companies Inc. - Key news
o Exhibit 127: Bausch Health Companies Inc. - Key offerings
o Exhibit 128: Bausch Health Companies Inc. - Segment focus
o 12.8 Bayer AG
o Exhibit 129: Bayer AG - Overview
o Exhibit 130: Bayer AG - Business segments
o Exhibit 131: Bayer AG - Key news
o Exhibit 132: Bayer AG - Key offerings
o Exhibit 133: Bayer AG - Segment focus
o 12.9 Bio Thera Bio Pharmaceutical Co. Ltd.
o Exhibit 134: Bio Thera Bio Pharmaceutical Co. Ltd. - Overview
o Exhibit 135: Bio Thera Bio Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 136: Bio Thera Bio Pharmaceutical Co. Ltd. - Key offerings
o 12.10 Biocon Ltd.
o Exhibit 137: Biocon Ltd. - Overview
o Exhibit 138: Biocon Ltd. - Business segments
o Exhibit 139: Biocon Ltd. - Key offerings
o Exhibit 140: Biocon Ltd. - Segment focus
o 12.11 F. Hoffmann La Roche Ltd.
o Exhibit 141: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 142: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 143: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 144: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 145: F. Hoffmann La Roche Ltd. - Segment focus
o 12.12 IVERIC bio Inc.
o Exhibit 146: IVERIC bio Inc. - Overview
o Exhibit 147: IVERIC bio Inc. - Product / Service
o Exhibit 148: IVERIC bio Inc. - Key offerings
o 12.13 Lupin Ltd.
o Exhibit 149: Lupin Ltd. - Overview
o Exhibit 150: Lupin Ltd. - Product / Service
o Exhibit 151: Lupin Ltd. - Key news
o Exhibit 152: Lupin Ltd. - Key offerings
o 12.14 Novartis AG
o Exhibit 153: Novartis AG - Overview
o Exhibit 154: Novartis AG - Business segments
o Exhibit 155: Novartis AG - Key offerings
o Exhibit 156: Novartis AG - Segment focus
o 12.15 Outlook Therapeutics Inc.
o Exhibit 157: Outlook Therapeutics Inc. - Overview
o Exhibit 158: Outlook Therapeutics Inc. - Product / Service
o Exhibit 159: Outlook Therapeutics Inc. - Key offerings
o 12.16 Pfizer Inc.
o Exhibit 160: Pfizer Inc. - Overview
o Exhibit 161: Pfizer Inc. - Product / Service
o Exhibit 162: Pfizer Inc. - Key news
o Exhibit 163: Pfizer Inc. - Key offerings
o 12.17 Regeneron Pharmaceuticals Inc.
o Exhibit 164: Regeneron Pharmaceuticals Inc. - Overview
o Exhibit 165: Regeneron Pharmaceuticals Inc. - Product / Service
o Exhibit 166: Regeneron Pharmaceuticals Inc. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 167: Inclusions checklist
o Exhibit 168: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 169: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 170: Research methodology
o Exhibit 171: Validation techniques employed for market sizing
o Exhibit 172: Information sources
o 13.5 List of abbreviations
o Exhibit 173: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global age-related macular degeneration (amd) market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Wet AMD - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Wet AMD - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Wet AMD - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Wet AMD - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Dry AMD - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Dry AMD - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Dry AMD - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Dry AMD - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Type ($ billion)
Exhibits43: Data Table on Market opportunity by Type ($ billion)
Exhibits44: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits45: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Specialty pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Specialty pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Specialty pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Specialty pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by Distribution Channel ($ billion)
Exhibits61: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ billion)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AbbVie Inc. - Overview
Exhibits112: AbbVie Inc. - Product / Service
Exhibits113: AbbVie Inc. - Key news
Exhibits114: AbbVie Inc. - Key offerings
Exhibits115: Alkeus Pharmaceuticals Inc. - Overview
Exhibits116: Alkeus Pharmaceuticals Inc. - Product / Service
Exhibits117: Alkeus Pharmaceuticals Inc. - Key offerings
Exhibits118: Amgen Inc. - Overview
Exhibits119: Amgen Inc. - Product / Service
Exhibits120: Amgen Inc. - Key offerings
Exhibits121: Apellis Pharmaceuticals Inc. - Overview
Exhibits122: Apellis Pharmaceuticals Inc. - Product / Service
Exhibits123: Apellis Pharmaceuticals Inc. - Key offerings
Exhibits124: Bausch Health Companies Inc. - Overview
Exhibits125: Bausch Health Companies Inc. - Business segments
Exhibits126: Bausch Health Companies Inc. - Key news
Exhibits127: Bausch Health Companies Inc. - Key offerings
Exhibits128: Bausch Health Companies Inc. - Segment focus
Exhibits129: Bayer AG - Overview
Exhibits130: Bayer AG - Business segments
Exhibits131: Bayer AG - Key news
Exhibits132: Bayer AG - Key offerings
Exhibits133: Bayer AG - Segment focus
Exhibits134: Bio Thera Bio Pharmaceutical Co. Ltd. - Overview
Exhibits135: Bio Thera Bio Pharmaceutical Co. Ltd. - Product / Service
Exhibits136: Bio Thera Bio Pharmaceutical Co. Ltd. - Key offerings
Exhibits137: Biocon Ltd. - Overview
Exhibits138: Biocon Ltd. - Business segments
Exhibits139: Biocon Ltd. - Key offerings
Exhibits140: Biocon Ltd. - Segment focus
Exhibits141: F. Hoffmann La Roche Ltd. - Overview
Exhibits142: F. Hoffmann La Roche Ltd. - Business segments
Exhibits143: F. Hoffmann La Roche Ltd. - Key news
Exhibits144: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits145: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits146: IVERIC bio Inc. - Overview
Exhibits147: IVERIC bio Inc. - Product / Service
Exhibits148: IVERIC bio Inc. - Key offerings
Exhibits149: Lupin Ltd. - Overview
Exhibits150: Lupin Ltd. - Product / Service
Exhibits151: Lupin Ltd. - Key news
Exhibits152: Lupin Ltd. - Key offerings
Exhibits153: Novartis AG - Overview
Exhibits154: Novartis AG - Business segments
Exhibits155: Novartis AG - Key offerings
Exhibits156: Novartis AG - Segment focus
Exhibits157: Outlook Therapeutics Inc. - Overview
Exhibits158: Outlook Therapeutics Inc. - Product / Service
Exhibits159: Outlook Therapeutics Inc. - Key offerings
Exhibits160: Pfizer Inc. - Overview
Exhibits161: Pfizer Inc. - Product / Service
Exhibits162: Pfizer Inc. - Key news
Exhibits163: Pfizer Inc. - Key offerings
Exhibits164: Regeneron Pharmaceuticals Inc. - Overview
Exhibits165: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits166: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits167: Inclusions checklist
Exhibits168: Exclusions checklist
Exhibits169: Currency conversion rates for US$
Exhibits170: Research methodology
Exhibits171: Validation techniques employed for market sizing
Exhibits172: Information sources
Exhibits173: List of abbreviations